(Q30845303)

27 June 2017

1 reference

title

Management of glaucoma: focus on pharmacological therapy (English)

1 reference

27 June 2017

1 reference

Robert E Marquis

1

1 reference

27 June 2017

Jess T Whitson

series ordinal

2

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

27 June 2017

1 reference

27 June 2017

volume

22

1 reference

27 June 2017

issue

1

1 reference

27 June 2017

page(s)

1-21

1 reference

A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.

27 June 2017

cites work

1 reference

12 December 2020

Hematologic reactions to carbonic anhydrase inhibitors

1 reference

12 December 2020

Dipivalyl epinephrine: a new pro-drug in the treatment of glaucoma

1 reference

12 December 2020

Shock-induced optic neuropathy: a cause of nonprogressive glaucoma

1 reference

12 December 2020

Models of open-angle glaucoma prevalence and incidence in the United States.

1 reference

12 December 2020

A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.

1 reference

12 December 2020

Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure

1 reference

12 December 2020

Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study

1 reference

12 December 2020

Trans-scleral application of a semiconductor diode laser

1 reference

12 December 2020

Effects of long-term treatment with timolol on lacrimal gland function

1 reference

12 December 2020

Update on prostaglandin analogs.

1 reference

12 December 2020

A Clinical Trial of Metipranolol, a Noncardioselective Beta-Adrenergic Antagonist, in Ocular Hypertension

1 reference

12 December 2020

The mechanism of timolol in lowering intraocular pressure. In the normal eye.

1 reference

12 December 2020

Brimonidine Purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension

1 reference

12 December 2020

Echothiophate iodide therapy in children. Effect upon blood cholinesterase levels.

1 reference

12 December 2020

The adrenergic receptors of the intraocular muscles of the human eye

1 reference

12 December 2020

Adverse reactions from timolol administration

1 reference

12 December 2020

Metipranolol-associated granulomatous anterior uveitis

1 reference

12 December 2020

Effects of brimonidine on aqueous humor dynamics in human eyes

1 reference

12 December 2020

1 reference

12 December 2020

Effects of iris pigmentation on response of ocular pressure to timolol

1 reference

12 December 2020

Studies of factors involved in the production of low tension glaucoma

1 reference

12 December 2020

Decreased formation of aqueous humour in insulin-dependent diabetic patients

1 reference

12 December 2020

Mitomycin as adjunct chemotherapy with trabeculectomy

1 reference

12 December 2020

Timolol-associated myasthenia gravis

1 reference

12 December 2020

Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure

1 reference

12 December 2020

Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham eye study

1 reference

12 December 2020

Trabeculectomy. Preliminary report of a new method

1 reference

12 December 2020

The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group

1 reference

12 December 2020

Laser Therapy for Open Angle Glaucoma

1 reference

12 December 2020

Once-daily versus twice-daily levobunolol (0.5%) therapy. A crossover study.

1 reference

12 December 2020

Effects of topical betaxolol in ocular hypertensive patients

1 reference

12 December 2020

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

12 December 2020

Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension

1 reference

12 December 2020

A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group

1 reference

12 December 2020

The prevalence of glaucoma among Eskimos of northwest Alaska

1 reference

12 December 2020

A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group

1 reference

12 December 2020

Effect of temperature and light on the stability of latanoprost and its clinical relevance

1 reference

12 December 2020

Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas

1 reference

12 December 2020

Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany.

1 reference

12 December 2020

Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma.

1 reference

12 December 2020

A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study

1 reference

12 December 2020

Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry

1 reference

12 December 2020

The dose response of human intraocular pressure to pilocarpine

1 reference

12 December 2020

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

1 reference

12 December 2020

Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group

1 reference

12 December 2020

Cryosurgery for the Treatment of Glaucoma*

1 reference

12 December 2020

Epinephrine maculopathy

1 reference

12 December 2020

Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics

1 reference

12 December 2020

Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability

1 reference

12 December 2020

Argon laser trabeculoplasty in the presurgical glaucoma patient.

1 reference

12 December 2020

[Metipranolol 0.1% and pilocarpine 2% as a fixed combination compared to each substance alone in the treatment of glaucoma. A controlled, randomized clinical study comparing the intraindividual effects and tolerance]

1 reference

12 December 2020

Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma

1 reference

12 December 2020

Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension

1 reference

12 December 2020

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

12 December 2020

Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension

1 reference

12 December 2020

The safety and efficacy of timolol 0.5% in xanthan gum versus timolol gel forming solution 0.5%.

1 reference

12 December 2020

Ca2+ channel-blocking activity of propranolol and betaxolol in isolated bovine retinal microartery

1 reference

12 December 2020

A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study Group

1 reference

12 December 2020

Long-term evaluation of 0.25% levobunolol and timolol for therapy for elevated intraocular pressure.

1 reference

12 December 2020

Follicular conjunctivitis associated with apraclonidine

1 reference

12 December 2020

A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals

1 reference

12 December 2020

Travoprost--a new prostaglandin analogue for the treatment of glaucoma

1 reference

12 December 2020

Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure.

1 reference

12 December 2020

Early intraocular pressure response following laser trabeculoplasty

1 reference

12 December 2020

Rate of flow of aqueous humor determined from measurements of aqueous flare.

1 reference

12 December 2020

Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow.

1 reference

12 December 2020

The effect of reduced eyedrop size and eyelid closure on the therapeutic index of phenylephrine

1 reference

12 December 2020

Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population

1 reference

12 December 2020

A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial

1 reference

12 December 2020

Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep.

1 reference

12 December 2020

Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure

1 reference

12 December 2020

The mechanism of betaxolol, a new ocular hypotensive agent.

1 reference

12 December 2020

Effectiveness and tolerance of metipranolol--results of a multi-center long-term study in Switzerland

1 reference

12 December 2020

Irreversible corneal decompensation in patients treated with topical dorzolamide

1 reference

12 December 2020

Long-term drift and continued efficacy after multiyear timolol therapy

1 reference

12 December 2020

Influence of betaxolol and timolol on the visual fields of patients with glaucoma.

1 reference

12 December 2020

Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes

1 reference

12 December 2020

A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension

1 reference

12 December 2020

Epidemiology of glaucoma in Japan--a nationwide glaucoma survey

1 reference

12 December 2020

Metipranolol-associated granulomatous iritis

1 reference

12 December 2020

Mechanism of action of bimatoprost (Lumigan).

1 reference

12 December 2020

Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma

1 reference

12 December 2020

Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).

1 reference

12 December 2020

Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist

1 reference

12 December 2020

1 reference

12 December 2020

Clinical experience with the long-term use of 1% apraclonidine. Incidence of allergic reactions

1 reference

12 December 2020

Blood circulation and fluid dynamics in the eye

1 reference

12 December 2020

Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting

1 reference

12 December 2020

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

1 reference

12 December 2020

Comparison of the effect of pilocarpine and echothiophate on intraocular pressure and outflow facility

1 reference

12 December 2020

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

12 December 2020

The decline in aqueous secretion and outflow facility with age

1 reference

12 December 2020

Respiratory difficulties with betaxolol

1 reference

12 December 2020

Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfort

1 reference

12 December 2020

Clinical, structural and molecular phototherapy effects of laser irradiation on the trabecular meshwork of human glaucomatous eyes

1 reference

12 December 2020

Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis

1 reference

12 December 2020

Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes.

1 reference

12 December 2020

Effects of Topical Betaxolol, Timolol, and Placebo on Pulmonary Function in Asthmatic Bronchitis

1 reference

12 December 2020

Short-term Effects of Unilateral 1% Apraclonidine Therapy

1 reference

12 December 2020

A controlled five-year follow-up study of laser trabeculoplasty as primary therapy for open-angle glaucoma

1 reference

12 December 2020

Effectiveness of nonpenetrating trabeculectomy in aphakic patients with glaucoma

1 reference

12 December 2020

Incidence of lens changes in patients treated with echothiophate iodide

1 reference

12 December 2020

Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study

1 reference

12 December 2020

A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

1 reference

12 December 2020

[Latanoprost-associated recurrent herpes simplex keratitis]

1 reference

12 December 2020

Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report

1 reference

12 December 2020

Interim report: National Registry of possible Drug-induced Ocular Side Effects

1 reference

12 December 2020

Global data on blindness

1 reference

12 December 2020

A double-masked comparison of carteolol and timolol in ocular hypertension

1 reference

12 December 2020

Topical beta-blocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol

1 reference

12 December 2020

Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.

1 reference

12 December 2020

Betaxolol and restrictive airway disease. Case report

1 reference

12 December 2020

Adverse effects experienced by patients taking timolol

1 reference

12 December 2020

Complications of laser trabeculoplasty

1 reference

12 December 2020

Aqueous humor dynamics in experimental iridocyclitis

1 reference

12 December 2020

Dipivefrin and epinephrine treatment of elevated intraocular pressure: a comparative study

1 reference

12 December 2020

A randomized study of 5-fluorouracil and filtration surgery

1 reference

12 December 2020

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study

1 reference

12 December 2020

Timolol: Its Effectiveness in Different Types of Glaucoma

1 reference

12 December 2020

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial

1 reference

12 December 2020

Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension

1 reference

12 December 2020

Additive intraocular pressure lowering effect of various medications with latanoprost

1 reference

12 December 2020

The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.

1 reference

12 December 2020

Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial

1 reference

12 December 2020

Effects of apraclonidine on aqueous humor dynamics in human eyes

1 reference

12 December 2020

Long-term effect of ophthalmic beta-adrenoceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma

1 reference

12 December 2020

Optic disk and visual field correlations in primary open-angle and low-tension glaucoma.

1 reference

12 December 2020

The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color.

1 reference

12 December 2020

Impact of intraocular pressure regulation on visual fields in open-angle glaucoma

1 reference

12 December 2020

The Effect of Latanoprost, Brimonidine, and a Fixed Combination of Timolol and Dorzolamide on Circadian Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension

1 reference

12 December 2020

A 'black cornea' secondary to topical epinephrine

1 reference

12 December 2020

The ocular hypotensive effect of the combination of latanoprost with dorzolamide

1 reference

12 December 2020

Non-penetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma surgery.

1 reference

12 December 2020

56,000 ways to treat glaucoma

1 reference

12 December 2020

Dynamics of transport systems in the eye. Friedenwald Lecture

1 reference

12 December 2020

Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level

1 reference

12 December 2020

Decreased intraocular pressure in the hypertensive human eye with betaxolol, a beta 1-adrenergic antagonist.

1 reference

12 December 2020

A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III

1 reference

12 December 2020

The effect of the water-drinking test on aqueous humor dynamics in healthy volunteers

1 reference

12 December 2020

The lack of respiratory effects of the ocular hypotensive drug latanoprost in patients with moderate-steroid treated asthma

1 reference

12 December 2020

Intraocular pressure response to replacing pilocarpine with carbachol.

1 reference

12 December 2020

Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide

1 reference

12 December 2020

Long-Term Control of Adult Open Angle Glaucoma by Argon Laser Treatment

1 reference

12 December 2020

The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-phenyl-trinor PGF2alpha by human and rabbit ocular tissue

1 reference

12 December 2020

Ophthalmic timolol treatment causing altered hypoglycemic response in a diabetic patient.

1 reference

12 December 2020

Effect of clonidine on aqueous humor flow in normal human eyes

1 reference

12 December 2020

The relaxant action of betaxolol on isolated bovine retinal microarteries

1 reference

12 December 2020

A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data

1 reference

12 December 2020

A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma

1 reference

12 December 2020

Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha

1 reference

12 December 2020

Levobunolol compared with timolol: a four-year study

1 reference

12 December 2020

Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group

1 reference

12 December 2020

Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension

1 reference

12 December 2020

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure

1 reference

12 December 2020

Topical epinephrine therapy of open-angel glaucoma.

1 reference

12 December 2020

Glaucoma: systemic side effects of topical medical therapy--a common and under recognized problem.

1 reference

12 December 2020

Early postmarketing surveillance of betaxolol hydrochloride, September 1985-September 1986

1 reference

12 December 2020

Latanoprost-associated cystoid macular edema

1 reference

12 December 2020

Early Effect of Epinephrine on Aqueous Formation in the Normal Human Eye

1 reference

12 December 2020

Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension

1 reference

12 December 2020

The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects

1 reference

12 December 2020

Argon laser therapy for open-angle glaucoma. A pilot study

1 reference

12 December 2020

A double-masked study of timolol and pilocarpine combined.

1 reference

12 December 2020

An update on bimatoprost in glaucoma therapy

1 reference

12 December 2020

The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group

1 reference

12 December 2020

Recent developments in glaucoma drainage implant surgery.

1 reference

12 December 2020

Anterior uveitis associated with latanoprost

1 reference

12 December 2020

Changing paradigms in the medical treatment of glaucoma

1 reference

12 December 2020

Congestive heart failure from betaxolol. Case report.

1 reference

12 December 2020

Adrenochrome pigmentation

1 reference

12 December 2020

Racial differences in the cause-specific prevalence of blindness in east Baltimore

1 reference

12 December 2020

Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial

1 reference

12 December 2020

Pigmentary dispersion and glaucoma. A new theory

1 reference

12 December 2020

10.2165/00002512-200522010-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

27 June 2017

1045684225

0 references

1 reference